Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Total Debt (2023 - 2026)

BioAge Labs' Total Debt history spans 3 years, with the latest figure at $2.6 million for Q4 2025.

  • On a quarterly basis, Total Debt fell 68.85% to $2.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 million, a 68.85% decrease, with the full-year FY2025 number at $2.6 million, down 68.85% from a year prior.
  • Total Debt hit $2.6 million in Q4 2025 for BioAge Labs, down from $4.1 million in the prior quarter.
  • Over the last five years, Total Debt for BIOA hit a ceiling of $14.2 million in Q4 2023 and a floor of $2.6 million in Q4 2025.
  • Historically, Total Debt has averaged $7.4 million across 3 years, with a median of $7.1 million in 2025.
  • Biggest five-year swings in Total Debt: crashed 40.13% in 2024 and later crashed 68.85% in 2025.
  • Tracing BIOA's Total Debt over 3 years: stood at $14.2 million in 2023, then tumbled by 40.13% to $8.5 million in 2024, then crashed by 68.85% to $2.6 million in 2025.
  • Business Quant data shows Total Debt for BIOA at $2.6 million in Q4 2025, $4.1 million in Q3 2025, and $5.6 million in Q2 2025.